Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Hepatology. 2016 Feb 19;64(1):200–208. doi: 10.1002/hep.28414

Table 1.

Details of cirrhotic patients who did not require 3-month readmission compared to those who did. All non-percentage values are in mean ± SD and significant p-values are in bold.

Not readmitted in 3 months (n=478) Readmitted in 3 months (n=535) P-value

Age 57.2 ± 10.0 57.0 ± 10.2 0.82

Male Gender 62% 65% 0.37

Alcoholic etiology 43% 43% 0.95

Diabetes 33% 40% 0.03

On date of index admission

Admitted with infection 29% 26% 0.32

WBC count (/1000 mm3) 6.8 ± 4.7 6.8 ± 4.3 0.88

Serum albumin (g/dl) 2.83 ± 0.64 2.73 ± 0.65 0.02

MELD score 17.24 ± 6.58 18.95 ± 6.60 0.0001

PPI 53% 60% 0.05

Beta-blockers 44% 42% 0.48

SBP prophylaxis 13% 22% 0.0002

Lactulose 50% 61% 0.0005

Rifaximin 35% 41% 0.06

Insurance Coverage 0.60
 Medicaid 8% 10%
 Medicare 43% 39%
 Supplemental 1% 1%
 Private 38% 38%
 VA 5% 6%
 None 6% 8%

During the index stay

Grade 3/4 HE 11% 15% 0.06

Need for dialysis 8% 9% 0.36

Need for mechanical ventilation 6% 6% 0.83

Shock 3% 2% 0.59

Nosocomial infection 49% 55% 0.21

Length of stay 9.5 ± 10.5 9.3 ± 8.7 0.84
On the date of discharge from the index readmission
WBC count (/1000 mm3) 3.9 ± 5.9 3.9 ± 6.5 0.92

Serum albumin (g/dl) 3.31 ± 3.16 3.35 ± 3.58 0.89

MELD score 16.30 ± 6.59 18.70 ± 6.45 0.0001

PPI 63% 67% 0.21

Beta-blockers 43% 38% 0.09

SBP prophylaxis 23% 29% 0.07

Lactulose 60% 68% 0.01

Rifaximin 44% 47% 0.45

Discharge location 0.74
Home 89% 90%
Nursing Home 11% 10%

HE: hepatic encephalopathy, WBC: white blood cell, PPI: proton pump inhibitors, SBP: spontaneous bacterial peritonitis, MELD: model for end-stage liver disease score (validated cirrhosis severity logarithmic score of INR, serum bilirubin and creatinine)